Stifel downgraded Roper Technologies (ROP) to Hold from Buy with a price target of $385, down from $550, post the Q4 report. The company’s Q3 issues persisted into Q4 as its 4% organic revenue growth fell short of the Street’s 5.5% expectation, the analyst tells investors in a research note. Stifel attributes the miss to another quarter of softer Deltek performance, continued tariff-related weakness in Neptune and lower networking perpetual-license revenue. While much of the bad news is now priced in, Roper’s 2026 outlook “does not appear fully de-risked” as it assumes a second half growth acceleration, contends the firm. It cites a lack of near-term catalysts for the downgrade.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ROP:
- Roper Technologies selloff appears overdone, says William Blair
- Oppenheimer downgrades Roper on organic growth challenges
- Roper Technologies downgraded to Perform from Outperform at Oppenheimer
- Roper Technologies price target lowered to $550 from $650 at Truist
- Midday Fly By: CMS proposal sinks insurers, UnitedHealth reports mixed Q4
